Repare Therapeutics Inc. Watch

from 10-K 12 pages Csw-#1 November 7, 2024 Void After November 7, 2029

from S-3 18 pages Repare Therapeutics Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Repare Therapeutics Inc. Form of Debt Securities Warrant Agreement

from S-3 20 pages Repare Therapeutics Inc. and , as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of Repare Therapeutics Inc. Form of Preferred Share Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3 20 pages Repare Therapeutics Inc. and , as Warrant Agent Form of Common Share Warrant Agreement Dated as of Repare Therapeutics Inc. Form of Common Share Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3 55 pages Repare Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities

from S-3ASR 18 pages Repare Therapeutics Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Repare Therapeutics Inc. Form of Debt Securities Warrant Agreement

from S-3ASR 20 pages Repare Therapeutics Inc. and , as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of Repare Therapeutics Inc. Form of Preferred Share Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3ASR 20 pages Repare Therapeutics Inc. and , as Warrant Agent Form of Common Share Warrant Agreement Dated as of Repare Therapeutics Inc. Form of Common Share Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates

from S-3ASR 55 pages Repare Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities

from 10-K 2 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-1/A 2 pages Indenture or similar

from S-1 16 pages The Company (As Defined Below) Is Not a “Reporting Issuer” as Such Term Is Defined Under Applicable Canadian Securities Laws. There Is No Assurance That the Company Will Become a “Reporting Issuer”. This Warrant and the Securities Issuable Upon Exercise Hereof Will Be Subject to Resale Restrictions Under Applicable Canadian Securities Laws. Unless Permitted Under Applicable Canadian Securities Legislation, the Holder of This Warrant and Any Securities Issuable Upon Exercise Hereof Must Not Trade the Warrant or Such Securities Before the Date That Is 4 Months and a Day After the Later of (A) the Effective Date (As Defined Below) and (B) the Date the Company Became a Reporting Issuer in Any Province or Territory of Canada

from S-1 58 pages Repare Therapeutics Inc. Amended and Restated Registration Rights Agreement September 3, 2019

from DRS 58 pages Repare Therapeutics Inc. Amended and Restated Registration Rights Agreement September 3, 2019